CC BY-NC-ND 4.0 · Journal of Coloproctology 2021; 41(03): 228-233
DOI: 10.1055/s-0041-1730261
Original Article

Evaluation of the Serrated Lesions Detection Rate and Its Role as a Colonoscopy Quality Criteria

1   Pontifícia Universidade Católica de Campinas, Campinas, SP, Brazil
,
1   Pontifícia Universidade Católica de Campinas, Campinas, SP, Brazil
,
2   Centro Universitário UNIFACID, Teresina, PI, Brazil
› Author Affiliations

Abstract

Objectives To evaluate the serrated lesion detection rate in colonoscopy at a specialized clinic and its role as quality criteria for endoscopic examination.

Methods This is an observational cross-sectional study with all patients that underwent colonoscopy between October 2018 and May 2019, performed by an experimented physician. A questionnaire was answered before the examination by the patient, and another questionnaire after the colonoscopy was answered by the medical team. All polyps identified were removed and sent to the same pathologist for analysis.

Results A total of 1,000 colonoscopies were evaluated. The average age of the patients was 58.9 years old, and most of them were female (60.6%). In 62.5% of the procedures, polyps were removed, obtaining a total of 1,730 polyps, of which 529 were serrated lesions, being 272 sessile serrated lesions (SSL). This data resulted in a serrated lesion detection rate (SDR) of 29.2%, and of 14% when considering only the SSL detection rate (SSLDR). The right colon had higher rates, with 22.3% SDR and 15.3% SSLDR. Screening colonoscopies also presented a higher serrated detection rate, of 20%, followed by diagnostics and follow-up exams. Smoking was the only risk factor associated with higher serrated detection rate.

Conclusions The serrated lesion detection rate is higher than the ones already previously suggested and the have the higher rates were stablished in the right colon and on screening exams.



Publication History

Received: 16 September 2020

Accepted: 18 January 2021

Article published online:
20 September 2021

© 2021. Sociedade Brasileira de Coloproctologia. This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commecial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/)

Thieme Revinter Publicações Ltda.
Rua do Matoso 170, Rio de Janeiro, RJ, CEP 20270-135, Brazil

 
  • References

  • 1 GLOBOCAN. Cancer Today, Global Cancer Observatory, 2018. Available from: http://gco.iarc.fr/
  • 2 Snover DC. Update on the serrated pathway to colorectal carcinoma. Hum Pathol 2011; 42 (01) 1-10
  • 3 Bettington M, Walker N, Clouston A, Brown I, Leggett B, Whitehall V. The serrated pathway to colorectal carcinoma: current concepts and challenges. Histopathology 2013; 62 (03) 367-386
  • 4 Brenner H, Kloor M, Pox CP. Colorectal cancer. Lancet 2014; 383 (9927): 1490-1502
  • 5 Nagtegaal ID, Odze RD, Klimstra D. et al; WHO Classification of Tumours Editorial Board. The 2019 WHO classification of tumours of the digestive system. Histopathology 2020; 76 (02) 182-188
  • 6 Moussata D, Boschetti G, Chauvenet M. et al. Endoscopic and histologic characteristics of serrated lesions. World J Gastroenterol 2015; 21 (10) 2896-2904
  • 7 East JE, Atkin WS, Bateman AC. et al. British Society of Gastroenterology position statement on serrated polyps in the colon and rectum. Gut 2017; 66 (07) 1181-1196
  • 8 Kaminski MF, Regula J, Kraszewska E. et al. Quality indicators for colonoscopy and the risk of interval cancer. N Engl J Med 2010; 362 (19) 1795-1803
  • 9 Lee HH, Lee BI. Image-Enhanced Endoscopy in Lower Gastrointestinal Diseases: Present and Future. Clin Endosc 2018; 51 (06) 534-540
  • 10 Arain MA, Sawhney M, Sheikh S. et al. CIMP status of interval colon cancers: another piece to the puzzle. Am J Gastroenterol 2010; 105 (05) 1189-1195
  • 11 Mouchli MA, Ouk L, Scheitel MR. et al. Colonoscopy surveillance for high risk polyps does not always prevent colorectal cancer. World J Gastroenterol 2018; 24 (08) 905-916
  • 12 Zorzi M, Senore C, Da Re F. et al; Equipe Working Group. Detection rate and predictive factors of sessile serrated polyps in an organised colorectal cancer screening programme with immunochemical faecal occult blood test: the EQuIPE study (Evaluating Quality Indicators of the Performance of Endoscopy). Gut 2017; 66 (07) 1233-1240
  • 13 Anderson JC, Butterly LF, Goodrich M, Robinson CM, Weiss JE. Differences in detection rates of adenomas and serrated polyps in screening versus surveillance colonoscopies, based on the new hampshire colonoscopy registry. Clin Gastroenterol Hepatol 2013; 11 (10) 1308-1312
  • 14 van Herwaarden YJ, Pape S, Vink-Börger E. et al. Reasons why the diagnosis of serrated polyposis syndrome is missed. Eur J Gastroenterol Hepatol 2019; 31 (03) 340-344
  • 15 Lam YF, Leung WK. The Importance of Increased Serrated Polyp Detection Rate. Curr Colorectal Cancer Rep 2016; 12: 81-87
  • 16 Rex DK, Schoenfeld PS, Cohen J. et al. Quality indicators for colonoscopy. Gastrointest Endosc 2015; 81 (01) 31-53
  • 17 Rex DK, Kahi C, O'Brien M. et al. The American Society for Gastrointestinal Endoscopy PIVI (Preservation and Incorporation of Valuable Endoscopic Innovations) on real-time endoscopic assessment of the histology of diminutive colorectal polyps. Gastrointest Endosc 2011; 73 (03) 419-422
  • 18 Clark BT, Parikh ND, Laine L. Yield of repeat forward-view examination of the right side of the colon in screening and surveillance colonoscopy. Gastrointest Endosc 2016; 84 (01) 126-132
  • 19 Anderson JC, Butterly LF, Weiss JE, Robinson CM. Providing data for serrated polyp detection rate benchmarks: an analysis of the New Hampshire Colonoscopy Registry. Gastrointest Endosc 2017; 85 (06) 1188-1194
  • 20 Kahi CJ, Hewett DG, Norton DL, Eckert GJ, Rex DK. Prevalence and variable detection of proximal colon serrated polyps during screening colonoscopy. Clin Gastroenterol Hepatol 2011; 9 (01) 42-46
  • 21 Ross WA, Thirumurthi S, Lynch PM. et al. Detection rates of premalignant polyps during screening colonoscopy: time to revise quality standards?. Gastrointest Endosc 2015; 81 (03) 567-574
  • 22 Payne SR, Church TR, Wandell M. et al. Endoscopic detection of proximal serrated lesions and pathologic identification of sessile serrated adenomas/polyps vary on the basis of center. Clin Gastroenterol Hepatol 2014; 12 (07) 1119-1126
  • 23 Abdeljawad K, Vemulapalli KC, Kahi CJ, Cummings OW, Snover DC, Rex DK. Sessile serrated polyp prevalence determined by a colonoscopist with a high lesion detection rate and an experienced pathologist. Gastrointest Endosc 2015; 81 (03) 517-524
  • 24 Meester R, Lansdop-Vogelaar I, Ladabaum U. What is the Prevalence of Serrated Colorectal Polyps, and What Does This Imply About Their Cancer Risk: A Systematic Literature Review. Gastroenterology 2019; 156 (06) 1084-1085 . Available from: https://www.sciencedirect.com/science/article/abs/pii/S0016508519396726
  • 25 Vleugels JL, IJspeert JE, Dekker E. Serrated lesions of the colon and rectum: the role of advanced endoscopic imaging. Best Pract Res Clin Gastroenterol 2015; 29 (04) 675-686
  • 26 Bettington M, Walker N, Rahman T. et al. High prevalence of sessile serrated adenomas in contemporary outpatient colonoscopy practice. Intern Med J 2017; 47 (03) 318-323
  • 27 Schramm C, Mbaya N, Franklin J. et al. Patient- and procedure-related factors affecting proximal and distal detection rates for polyps and adenomas: results from 1603 screening colonoscopies. Int J Colorectal Dis 2015; 30 (12) 1715-1722
  • 28 Occhipinti P, Saettone S, Cristina S, Ridola L, Hassan C. Correlation between adenoma and serrated lesion detection rates in an unselected outpatient population. Dig Liver Dis 2015; 47 (06) 508-511
  • 29 Weisenberger DJ, Levine AJ, Long TI. et al; Colon Cancer Family Registry. Association of the colorectal CpG island methylator phenotype with molecular features, risk factors, and family history. Cancer Epidemiol Biomarkers Prev 2015; 24 (03) 512-519
  • 30 Burnett-Hartman AN, Passarelli MN, Adams SV. et al. Differences in epidemiologic risk factors for colorectal adenomas and serrated polyps by lesion severity and anatomical site. Am J Epidemiol 2013; 177 (07) 625-637